On the press
The edition is loading.
What a biotech Cold War can teach us about building from within rather than blocking from fear.
Let the message about Christ, in all its richness, fill your lives. Teach and counsel each other with all the wisdom he gives. Sing psalms and hymns and spiritual songs to God with thankful hearts.
Colossians 3:16— NLTRead Colossians 3 (NLT)
A concise digest of source-backed Infolitico stories when the day has a truthful slate. Thin mornings are skipped rather than padded.
A Fortune article describes big pharma’s patent cliff as meeting a new biotech Cold War involving China. The article warns that slashing federal research budgets could hamstring scientists and cause the loss of an otherwise winnable race.
Its stated response is to outrun China, not outlaw it.
The warning points to a hard truth: the most visible threat is not always the one that decides the outcome. A patent cliff arrives on a calendar, with known drugs and expiring protections. Research capacity forms slowly, through labs, training, funding, and institutions that can keep learning over time.
Those two realities pull in different directions. Blocking or outlawing a competitor can look decisive, especially when the stakes are high. But the article’s concern is that a defensive move may feel strong while weakening the very scientists needed to compete. The tension is real: public safety and national interests can require limits, yet fear can also mistake control for wisdom.
Colossians 3:16 does not set research budgets or trade rules. It describes a community formed by Christ’s message, marked by teaching, counsel, wisdom, and gratitude. That is a different instinct from panic. When threats rise, the question is not only what we can prohibit, but what we are building: patient discernment, shared counsel, and capacity strong enough to meet uncertainty without being ruled by fear.
This Daily Reflection keeps the reported event, faith reflection, Scripture, and automation record distinct.
